A new retrospective study addresses the question of how often to screen for breast cancer, suggesting benefits to yearly screening.

Looking beyond DNA mutations to a combination of molecular features could help determine the best drug combinations for each patient.

Tests that provide molecular details on a specific tumor aren’t routinely done for pediatric brain tumors, but research suggests the extra step could change a child’s therapy.

The finding suggests a potential target in the metabolism that could slow or prevent breast cancer metastasis.

Bone filler device accelerates bone healing impaired by age or cancer treatment.

Three early-stage cancer drug projects receive pilot grants to help them advance from the bench toward the bedside.